CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
Saved in:
| Title: | CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. |
|---|---|
| Authors: | Kouzeli A; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., Collins PJ; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Metzemaekers M; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Meyrath M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Szpakowska M; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Artinger M; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland., Struyf S; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Proost P; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium., Chevigne A; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg., Legler DF; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland., Eberl M; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom., Moser B; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom. |
| Source: | Frontiers in immunology [Front Immunol] 2020 Oct 05; Vol. 11, pp. 561404. Date of Electronic Publication: 2020 Oct 05 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 33123134 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kouzeli+A%22">Kouzeli A</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Collins+PJ%22">Collins PJ</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Metzemaekers+M%22">Metzemaekers M</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Meyrath+M%22">Meyrath M</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Szpakowska+M%22">Szpakowska M</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Artinger+M%22">Artinger M</searchLink>; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Struyf+S%22">Struyf S</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Proost+P%22">Proost P</searchLink>; Laboratory of Molecular Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Chevigne+A%22">Chevigne A</searchLink>; Department of Infection and Immunity, Immuno-Pharmacology and Interactomics, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.<br /><searchLink fieldCode="AU" term="%22Legler+DF%22">Legler DF</searchLink>; Biotechnology Institute Thurgau (BITg), University of Konstanz, Kreuzlingen, Switzerland.<br /><searchLink fieldCode="AU" term="%22Eberl+M%22">Eberl M</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Moser+B%22">Moser B</searchLink>; Division of Infection and Immunity, Cardiff University School of Medicine, Cardiff, United Kingdom. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2020 Oct 05; Vol. 11, pp. 561404. <i>Date of Electronic Publication: </i>2020 Oct 05 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33123134 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2020.561404 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 561404 Titles: – TitleFull: CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kouzeli A – PersonEntity: Name: NameFull: Collins PJ – PersonEntity: Name: NameFull: Metzemaekers M – PersonEntity: Name: NameFull: Meyrath M – PersonEntity: Name: NameFull: Szpakowska M – PersonEntity: Name: NameFull: Artinger M – PersonEntity: Name: NameFull: Struyf S – PersonEntity: Name: NameFull: Proost P – PersonEntity: Name: NameFull: Chevigne A – PersonEntity: Name: NameFull: Legler DF – PersonEntity: Name: NameFull: Eberl M – PersonEntity: Name: NameFull: Moser B IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 10 Text: 2020 Oct 05 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 11 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |